WBIO 2026 Session Details
Session Details
DAY 1 11.24 (TUE) — World Stage
TimeProgramSPEAKER
10:00 – 10:30
Opening Ceremony
10:30 – 11:00
Keynote Speech
Future Strategies for K-Bio’s Global Advancement and
Innovation Pathways for the Osong Bio Cluster
11:00 – 12:00
Opening Panel Discussion
The Future of Osong and the Global Bio⁠·⁠Health Leap: Innovation, Investment & Infrastructure
(Chair) Hanlim Moon, President, Korean Society for Clinical Pharmacology and Therapeutics
Younghan Shin, Governor, Chungcheongbuk-do Province
Jangsub Lee, Mayor, Cheongju City
Yeonhee Lee, Member of the National Assembly
12:00 – 13:30
BREAK
13:30 – 14:10
Plenary Session Ⅰ
Evolving Regulatory Pathways for Early-Phase Clinical Trials of Biologics: Korea-Japan Collaboration in FIH Studies, Biosimilar Development, and Biomarker-Driven Approaches.
14:10 – 14:20
BREAK
14:20 – 15:00
Plenary Session Ⅱ
AI-Driven and Digital Transformation in Clinical Trials: Accelerating Global Drug Development through Intelligent Data Platforms.
15:00 – 15:10
BREAK
15:10 – 16:50
Industry & Clinical Session
Talk 1
Cell and Gene Therapy: Current Landscape, Future Perspectives, and CHA Biotech’s R&D Strategy
Talk 2
OHPAS™, PMT™, and Nexatecan™ Technologies for Enhanced ADC Efficacy and Safety
Talk 3
From Platform to Pipeline: Translational Strategies for Developing 4-1BB Bispecific T-cell Engagers and Bispecific ADCs

• The detailed program is subject to change depending on operational circumstances.